Disturbed immunoregulation in autoimmunity;Verstoorde immuunregulatie bij auto-immuniteit

Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde

Volumn 31, Issue 4, 2006, Pages 248-256

  Rijkers, G T ^a,b,c,d   Prakken, B J ^a,c,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c IACOPO Institute for Translational Medicine   (United States)

^d IACOPO Institute for Translational Medicine   (Netherlands)

Author keywords

Autoimmunity; Cytokine balance; Heat shock proteins; Regulatory T lymphocytes; Tolerance

Indexed keywords

ETANERCEPT; HEAT SHOCK PROTEIN; INFLIXIMAB; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; UNSPECIFIED SIDE EFFECT;

BACTERIA (MICROORGANISMS);

EID: 37049017188     PISSN: 15708306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol 2006; 24: 571-606.
2. Siggs OM, Makaroff LE, Liston A. The why and how of thymocyte negative selection. Curr Opin Immunol 2006; 18: 175-183.
3. Hooijkaas H, Smeenk R, Gmelig Meyeling F. Systemische auto-immuunziekten: passende serologische diagnostiek. Ned Tijdschr Klin Chem Labgeneesk 2006; 31: 257-268.
4. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004; 22: 307-328.
5. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006; 24: 65-97.
6. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th 17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677-688.
7. Jager W de, Prakken BJ, Bijlsma JW, Kuis W, Rijkers GT. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods 2005; 300: 124-135.
8. Rieux-Laucat F, Fischer A, Deist FL. Cell-death signaling and human disease. Curr Opin Immunol 2003; 15: 325-331.
9. Worth A, Thrasher AJ, Gaspar HB. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol 2006; 133: 124-140.
10. Jiang H, Chess L. Regulation of immune responses by T-cells. N Engl J Med 2006; 354: 1166-1176.
11. Hon S, Takahashi T, Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T-cells. Adv Immunol 2003; 81: 331-371.
12. Sakaguchi. Regulatory T cells: Meden Agan. Immunol Rev 2006; 212: 5-7.
13. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
14. Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease. Immunol Rev 2006; 212: 203-216.
15. Wraith DC, Nicolson KS, Whitley NT. Regulatory CD4+ T cells and the control of autoimmune disease. Curr Opin Immunol 2004; 16: 695-701.
16. Von Boehmer, H. Mechanisms of suppression by suppressor T-cells. Nature Immunol 2005; 6: 338-344.
17. LeBras S, Geha RS. IPEX and the role of FOXP3 in the development and function of human Tregs. J Clin Invest 2006; 116: 1473-1475.
18. + T-cells and the control of autoimmune disease. Curr Opinion Immunol 2004; 16: 695-701.
19. Taams LS, Palmer DB, Akbar AN, Robinson DS, Brown Z, Hawrylowicz CM. Regulatory T-cells in human disease and their potential for therapeutic manipulation. Immunology 2006; 118: 1-9.
20. Batstra MR, Drexhage HA. Auto-immuunziekten van endocriene organen. Ned Tijdschr Klin Chem Labgeneesk 2006; 31: 275-281.
21. Bakker-Jonges LE, van Buuren HR. Auto-immuunziekten van de lever. Ned Tijdschr Klin Chem Labgeneesk 2006; 31: 281-289.
22. Eden W van, Thole JE, Zee R van der, Noordzij A, Embden JD van, Hensen EJ, Cohen IR. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988; 331: 171-173.
23. Eden W van, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 1985; 82: 5117-5120.
24. Graeff-Meeder ER de, Eden W van, Rijkers GT, Prakken BJ, Kuis W, Voorhorst-Ogink MM, van der Zee R, Schuurman HJ, Helders PJ, Zegers BJ. Juvenile chronic arthritis: T-cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest 1995; 95: 934-940.
25. Prakken AB, Eden W van, Rijkers GT, Kuis W, Toebes EA, Graeff-Meeder ER de, Zee R van der, Zegers BJ. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996; 39: 1826-1832.
26. Kamphuis S, Kuis W, de Jager W, Teklenburg G, Massa M, Gordon G, Boerhof M, Rijkers GT, Uiterwaal CS, Otten HG, Sette A, Albani S, Prakken BJ. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 2005; 366: 50-56.
27. Kamphuis S, Albani S, Prakken BJ. Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T-cells in human arthritis. Expert Opin Biol Ther 2006; 6: 579-589.
28. Albani S, Prakken B. T-cell epitope-specific immune therapy for rheumatic diseases. Arthritis Rheumatism 2006; 54: 19-25.
29. Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, Maini RN. Anti-TNF therapy: where have we got to in 2005? J Autoimmun 2005; 25 Suppl: 26-28.
30. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 2275-2285.
31. Genovese MC. Biologic therapies in clinical development for the treatment of rheumatoid arthritis. J Clin Rheumatol 2005; 11: S45-S54.
32. Hansen S, Leslie RG. TGN1412: scrutinizing preclinical trials of antibody-based medicines. Nature 2006; 441: 282.
33. Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol 2005; 128: 432-459.
34. Kleer I de, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Yung GP, Albani S, Kuis W, Wulffraat N, Prakken B. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T-cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006 15; 107: 1696-1702.
35. Pearce SH, Merriman TR. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 2006; 12: 90-98.
36. Kleer IM de, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, Jager W de, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B. CD4+CD25 bright regulatory T-cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004; 172: 6435-6443.
37. Graeff-Meeder ER de, Rijkers GT, Voorhorst-Ogink MM, Kuis W, Zee R van der, Eden W van, Zegers BJ. Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr Res 1993; 34: 424-428.
38. Boog CJ, Graeff-Meeder ER de, Lucassen MA, Zee R van der, Voorhorst-Ogink MM, Kooten PJ van, Geuze HJ, Eden W van. Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J Exp Med 1992; 175: 1805-1810.